Reserpine manufacturers and suppliers

Reserpine suppliers

Properties

Melting point:: ~265 °C (dec.)

alpha: D23 -118° (CHCl3); D26 -164° (c = 0.96 in pyridine); D26 -168° (c = 0.624 in DMF)

Boiling point:: 655.12°C (rough estimate)

Density: 1.2336 (rough estimate)

refractive index: 177 ° (C=1, DMF)

Flash point:: 22℃

storage temp.: Inert atmosphere,Room Temperature

solubility: Practically insoluble in water, very slightly soluble in ethanol (96 per cent).

pka: 6.6(at 25℃)

form: Solid

color: Off-white

optical activity: [α]20/D 123±3°, c = 1% in chloroform

Water Solubility: Soluble in water.

Merck: 14,8145

BRN: 102014

Stability:: Stable, but darkens slowly in light. Combustible. Incompatible with strong acids, reducing agents, oxidizing agents.

InChIKey: QEVHRUUCFGRFIF-MDEJGZGSSA-N

SMILES: CO[C@H]1[C@@H](C[C@@H]2CN3CCc4c([nH]c5cc(OC)ccc45)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)c6cc(OC)c(OC)c(OC)c6

LogP: 4.050 (est)

CAS DataBase Reference: 50-55-5

NIST Chemistry Reference: Reserpine(50-55-5)

IARC: 3 (Vol. 24, Sup 7) 1987

EPA Substance Registry System: Reserpine (50-55-5)

Safety Information

Symbol(GHS): GHS07,GHS08

Signal word: Danger

Hazard statements: H302-H336-H351-H360D

Precautionary statements: P201-P301+P312+P330-P308+P313

target organs: Central nervous system

PPE: dust mask type N95 (US), Eyeshields, Faceshields, Gloves

Hazard Codes: Xn,Xi

Risk Statements: 22-67-36-10

Safety Statements: 22-36/37/39-26

RIDADR: 3077

WGK Germany: 3

RTECS: ZG0350000

F: 10-23

TSCA: TSCA listed

PackingGroup: II

HS Code: 29399990

Storage Class: 6.1C - Combustible acute toxic Cat.3
toxic compounds or compounds which causing chronic effects

Hazard Classifications: Acute Tox. 4 Oral
Carc. 2
Repr. 1A
STOT SE 3

Hazardous Substances Data: 50-55-5(Hazardous Substances Data)

Toxicity: LD50 oral in rat: 420mg/kg

Use

Reserpine is a drug that is used for the treatment of high blood pressure, usually in combination with a thiazide diuretic or vasodilator.Large clinical trials have shown that combined treatment with reserpine plus a thiazide diuretic reduces mortality of people with hypertension. Although the use of reserpine as a solo drug has declined since it was first approved by the FDA in 1955,the combined use of reserpine and a thiazide diuretic or vasodilator is still recommended in patients who do not achieve adequate lowering of blood pressure with first-line drug treatment alone.

You can find Reserpine suppliers, manufacturers, and distributors from countries such as CHINA, United States and the India here. Browse to the tetrahydrofuran product information displayed by the supplier, as well as the supplier's contact and capability information.